Finance

Lists
ABL:FRA
Abbott Laboratories
€ ८८.७०
+०.२०%
(+०.१८) 1D
सेप्टेम्बर ३०, ०८:००:४२ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABL...
Open
€ ८८.७०
High
€ ८८.७०
Low
€ ८८.७०
Mkt. cap
१.७५ खरब
Avg. vol.
२८१.००
Volume
०.००
52-wk high
€ ११५.००
52-wk low
€ ६९.७६
No. of employees
१ लाख
Open
€ ८८.७०
High
€ ८८.७०
Low
€ ८८.७०
Mkt. cap
१.७५ खरब
Avg. vol.
२८१.००
Volume
०.००
52-wk high
€ ११५.००
52-wk low
€ ६९.७६
No. of employees
१ लाख
News stories
From web sources and news partners
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEORobert B. Ford
Employees१.१५ लाख
Founded१८८८
Headquartersशिकागो, इलिनोइ, संयुक्त राज्य अमेरिका
Sector-
Websiteabbott.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
११.३७ अरब
११.४६ अरब
११.१६ अरब
१२.५९ अरब
Cost of goods sold
५.०८ अरब
४.९१ अरब
४.८९ अरब
५.३२ अरब
Cost of revenue
५.०८ अरब
४.९१ अरब
४.८९ अरब
५.३२ अरब
Research and development expenses
७६.६० करोड
७२.०० करोड
७६.७० करोड
८९.२० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.९० अरब
२.९३ अरब
३.५८ अरब
३.८७ अरब
Operating expense
४.०९ अरब
४.०७ अरब
४.७७ अरब
५.४२ अरब
Total operating expenses
९.१६ अरब
८.९८ अरब
९.६६ अरब
१०.७४ अरब
Operating income
२.२० अरब
२.४८ अरब
१.५० अरब
१.८५ अरब
Other non operating income
२०.०० लाख
-१.५० करोड
-
-२.५० करोड
EBT including unusual items
२.१८ अरब
२.३६ अरब
१.४५ अरब
१.५२ अरब
EBT excluding unusual items
२.१८ अरब
२.४४ अरब
१.४५ अरब
१.५२ अरब
Income tax expense
५३.६० करोड
५८.२० करोड
३७.२० करोड
५९.६० करोड
Effective tax rate
२४.५९%
२४.६८%
२५.६७%
३९.११%
Other operating expenses
-
-
-
-
Net income
१.६४ अरब
१.७८ अरब
१.०८ अरब
९२.८० करोड
Net profit margin
१४.४६%
१५.५०%
९.६५%
७.३७%
Earnings per share
१.३०
१.५०
१.१५
१.३१
Interest and investment income
७.७० करोड
७.८० करोड
१०.६० करोड
५.२० करोड
Interest expense
-१२.१० करोड
-१२.०० करोड
-१७.४० करोड
-३५.१० करोड
Net interest expenses
-४.४० करोड
-४.२० करोड
-६.८० करोड
-२९.९० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
३.०० अरब
३.२७ अरब
२.३१ अरब
२.९१ अरब
Gain or loss from assets sale
-
६.५० करोड
-
-
AI content may include mistakes. Learn more
Google एपहरू